Cigna is refusing to cover the biologic my rheumatologist prescribed for rheumatoid arthritis (Rinvoq, $6,800/month retail) and forcing "step therapy" through two drugs i already failed years ago under a different insurer. my employer plan is self-funded, so does Texas's step therapy override law even apply to me? and how do i document drug failures from an insurer that no longer exists in my records? also worried the copay accumulator is a second trap behind the first one.

diagnosed with rheumatoid arthritis in 2019, and i am now in week 11 of trying to get the medication my rheumatologist actually prescribed, while my hands get worse in real time. posting the whole situation because every individual answer i find online seems to assume a piece of my situation that is not true, and i suspect the combination i am stuck in is common enough that the full answer will help other people.

the history: between 2019 and 2021, under my old employer's insurance (United), i went through the standard progression - methotrexate for 14 months (constant nausea, liver enzymes elevated twice, inadequate response on top of it) and then sulfasalazine for about 8 months (no meaningful improvement, documented in my rheumatologist's notes the whole way). in 2021 my then-rheumatologist wanted to move me to a biologic, and then life happened: job change, insurance change, a move from oklahoma to texas, a new rheumatologist, and a couple of years where my disease was quiet enough that we coasted. it is not quiet anymore. march flare, visible joint changes on imaging, and my current rheumatologist prescribed Rinvoq (upadacitinib) based on my history and the specifics of my case.

the denial: Cigna (who administers my current employer's plan) rejected the prior authorization. their letter says the plan requires step therapy - i must try and fail a preferred TNF inhibitor (they list the Humira biosimilars) AND methotrexate before Rinvoq is covered. methotrexate. the drug i failed for 14 months with documented liver enzyme elevations. when my doctor's office pointed this out in the peer-to-peer, the reviewer's position was that the failures occurred "under a different benefit plan" and are "not reflected in the member's claim history," and that the documentation submitted (my old rheumatologist's chart notes) was "insufficient to establish therapeutic failure." my old rheumatologist has since retired and the practice was absorbed by a hospital system, which made even getting those notes a six-week project. the retail price if i just pay: $6,800/month. i cannot.

the wrinkle that i think changes all the standard advice: my employer's plan is self-funded - Cigna is just the administrator (it says "administered by" on the card, and HR confirmed the company pays its own claims). i have read that texas passed a step therapy override law with specific timelines and exception criteria, and i have ALSO read that state insurance laws do not apply to self-funded employer plans because of ERISA preemption. both statements cannot be fully useful to me at the same time.

the questions, numbered so the experts in here can go down the list:

(1) the formulary exception / step therapy exception request: what does a medical necessity letter that actually WINS one of these look like? my doctor's office submits what looks to me like a form with checkboxes and a paragraph. i keep reading that the letter has to do specific work. what is the specific work?

(2) does texas's step therapy override law (i believe it requires exceptions when the required drug was previously failed, and sets response deadlines) apply to a self-funded employer plan administered by Cigna, or does ERISA preemption knock it out? and if it does not apply, what federal rules DO give me exception rights and deadlines?

(3) how do i properly document drug failures from 4-6 years ago under a defunct practice and a different insurer? i have the absorbed hospital system's release of my old chart. is chart documentation enough, or do i need pharmacy fill records too (and can i still get 2019-2021 fill history from a pharmacy or from United)?

(4) the copay accumulator question, because i want to see the second trap before i step in it: IF i win coverage, Rinvoq's manufacturer copay card would cover most of my out-of-pocket. but my plan documents mention a "copay adjustment program," which i understand means the manufacturer assistance does NOT count toward my deductible or out-of-pocket max. does that mean i hit a wall mid-year when the card's annual max runs out and none of it counted? is there any way around an accumulator, and are these even legal everywhere?

(5) is there an expedited path? my disease is active, there are visible erosions on imaging since march, and the standard timeline of "submit, wait 15 days, appeal, wait 30 days" is measured in joint damage. what qualifies as urgent, and who decides?

(6) if the internal appeal fails, what does external review look like for a self-funded plan - is it a state process or a federal one, who actually performs the review, and what are the win rates like for specialty drug step therapy cases?

(7) my rheumatologist mentioned the manufacturer's bridge program could supply the drug free while the coverage fight runs. is there any way accepting free drug undermines the claim ("member is receiving the medication, therefore no urgency")? it feels like it should not matter and also like exactly the kind of thing that gets used against you.

(8) nuclear option: my spouse's open enrollment is in november and their plan (fully insured, texas) covers Rinvoq with normal specialty tier cost sharing, no step therapy flag that we can find. is "switch plans and stop fighting" actually the right answer here, or is that trading a known fight for an unknown one (new prior auth, new accumulator, mid-treatment transition)?

i have the denial letter, the peer-to-peer summary, my complete old chart, current imaging, and a rheumatologist who is willing to write whatever actually works. eleven weeks in. tell me how this game is won.